Cardiovascular risk and androgen deprivation therapy for prostate cancer: systematic review and meta-analysis of randomised controlled trials and observational studies (METADTCR)
Résumé
no abstract
Communication Dans Un Congrès
Année : 2015
Laurent Jonchère : Connectez-vous pour contacter le contributeur
https://univ-rennes.hal.science/hal-01198645
Soumis le : lundi 14 septembre 2015-10:40:42
Dernière modification le : lundi 22 janvier 2024-16:48:03
Dates et versions
Identifiants
- HAL Id : hal-01198645 , version 1
- DOI : 10.1016/j.clinthera.2015.05.017
Citer
L. -M. Scailteux, Florian Naudet, Q. Alimi, S. Vincendeau, E Oger. Cardiovascular risk and androgen deprivation therapy for prostate cancer: systematic review and meta-analysis of randomised controlled trials and observational studies (METADTCR). 12th Conference of the European Association for Clinical Pharmacology and Therapeutics, 2015, Madrid, Spain. pp.e3, ⟨10.1016/j.clinthera.2015.05.017⟩. ⟨hal-01198645⟩
Collections
64
Consultations
0
Téléchargements